Immunology of cancer stem cells in solid tumours. A review

Cristina Maccalli, Andrea Volontè, Carolina Cimminiello, Giorgio Parmiani

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) represent a minor subpopulation of tumour cells that share some features with the normal stem cells of the tissue from which tumour derives and have the properties of self-renewal, multiple differentiation and tumour initiation (tumour-initiating cells, TICs). Thus CSCs/TICs need to survive cancer therapies in order to provide new, more differentiated, metastatic-prone tumour cells. This occurs through different signals delivered within the tumour microenvironment. The immune system of cancer patients may recognise CSCs/TICs and kill them though it is unclear whether this may occur in vivo during spontaneous tumour growth. This review summarises findings on the immunological profile of CSCs/TICs as compared with neoplastic non-stem cells and discusses the possible antigens recognised by the patients' immune system, the in vitro and the potential in vivo immunogenicity of such antigens and the ability of human CSCs/TICs to down-regulate the immune response by the release of a variety of suppressive factors. We conclude that available data on immunological characterisation of CSCs/TICs may be useful in the perspective of designing new translational immunotherapy protocols targeting CSCs/TICs.

Original languageEnglish
Pages (from-to)649-655
Number of pages7
JournalEuropean Journal of Cancer
Volume50
Issue number3
DOIs
Publication statusPublished - Feb 2014
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Allergy and Immunology
Neoplasms
Immune System
Antigens
Tumor Microenvironment
Immunotherapy

Keywords

  • Cancer stem cells
  • Colorectal carcinoma
  • Glioblastoma
  • Immunogenicity
  • Immunosuppression

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Immunology of cancer stem cells in solid tumours. A review. / Maccalli, Cristina; Volontè, Andrea; Cimminiello, Carolina; Parmiani, Giorgio.

In: European Journal of Cancer, Vol. 50, No. 3, 02.2014, p. 649-655.

Research output: Contribution to journalReview article

Maccalli, Cristina ; Volontè, Andrea ; Cimminiello, Carolina ; Parmiani, Giorgio. / Immunology of cancer stem cells in solid tumours. A review. In: European Journal of Cancer. 2014 ; Vol. 50, No. 3. pp. 649-655.
@article{a068e990d5f44d1d813272c40398af60,
title = "Immunology of cancer stem cells in solid tumours. A review",
abstract = "Cancer stem cells (CSCs) represent a minor subpopulation of tumour cells that share some features with the normal stem cells of the tissue from which tumour derives and have the properties of self-renewal, multiple differentiation and tumour initiation (tumour-initiating cells, TICs). Thus CSCs/TICs need to survive cancer therapies in order to provide new, more differentiated, metastatic-prone tumour cells. This occurs through different signals delivered within the tumour microenvironment. The immune system of cancer patients may recognise CSCs/TICs and kill them though it is unclear whether this may occur in vivo during spontaneous tumour growth. This review summarises findings on the immunological profile of CSCs/TICs as compared with neoplastic non-stem cells and discusses the possible antigens recognised by the patients' immune system, the in vitro and the potential in vivo immunogenicity of such antigens and the ability of human CSCs/TICs to down-regulate the immune response by the release of a variety of suppressive factors. We conclude that available data on immunological characterisation of CSCs/TICs may be useful in the perspective of designing new translational immunotherapy protocols targeting CSCs/TICs.",
keywords = "Cancer stem cells, Colorectal carcinoma, Glioblastoma, Immunogenicity, Immunosuppression",
author = "Cristina Maccalli and Andrea Volont{\`e} and Carolina Cimminiello and Giorgio Parmiani",
year = "2014",
month = "2",
doi = "10.1016/j.ejca.2013.11.014",
language = "English",
volume = "50",
pages = "649--655",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Immunology of cancer stem cells in solid tumours. A review

AU - Maccalli, Cristina

AU - Volontè, Andrea

AU - Cimminiello, Carolina

AU - Parmiani, Giorgio

PY - 2014/2

Y1 - 2014/2

N2 - Cancer stem cells (CSCs) represent a minor subpopulation of tumour cells that share some features with the normal stem cells of the tissue from which tumour derives and have the properties of self-renewal, multiple differentiation and tumour initiation (tumour-initiating cells, TICs). Thus CSCs/TICs need to survive cancer therapies in order to provide new, more differentiated, metastatic-prone tumour cells. This occurs through different signals delivered within the tumour microenvironment. The immune system of cancer patients may recognise CSCs/TICs and kill them though it is unclear whether this may occur in vivo during spontaneous tumour growth. This review summarises findings on the immunological profile of CSCs/TICs as compared with neoplastic non-stem cells and discusses the possible antigens recognised by the patients' immune system, the in vitro and the potential in vivo immunogenicity of such antigens and the ability of human CSCs/TICs to down-regulate the immune response by the release of a variety of suppressive factors. We conclude that available data on immunological characterisation of CSCs/TICs may be useful in the perspective of designing new translational immunotherapy protocols targeting CSCs/TICs.

AB - Cancer stem cells (CSCs) represent a minor subpopulation of tumour cells that share some features with the normal stem cells of the tissue from which tumour derives and have the properties of self-renewal, multiple differentiation and tumour initiation (tumour-initiating cells, TICs). Thus CSCs/TICs need to survive cancer therapies in order to provide new, more differentiated, metastatic-prone tumour cells. This occurs through different signals delivered within the tumour microenvironment. The immune system of cancer patients may recognise CSCs/TICs and kill them though it is unclear whether this may occur in vivo during spontaneous tumour growth. This review summarises findings on the immunological profile of CSCs/TICs as compared with neoplastic non-stem cells and discusses the possible antigens recognised by the patients' immune system, the in vitro and the potential in vivo immunogenicity of such antigens and the ability of human CSCs/TICs to down-regulate the immune response by the release of a variety of suppressive factors. We conclude that available data on immunological characterisation of CSCs/TICs may be useful in the perspective of designing new translational immunotherapy protocols targeting CSCs/TICs.

KW - Cancer stem cells

KW - Colorectal carcinoma

KW - Glioblastoma

KW - Immunogenicity

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=84893642085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893642085&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2013.11.014

DO - 10.1016/j.ejca.2013.11.014

M3 - Review article

C2 - 24333096

AN - SCOPUS:84893642085

VL - 50

SP - 649

EP - 655

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 3

ER -